Related Experiment Video
Updated: Jun 14, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Prion-like disorders: blurring the divide between transmissibility and infectivity
Mimi Cushman1, Brian S Johnson, Oliver D King
1Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, 805b Stellar-Chance Laboratories, 422 Curie Boulevard, Philadelphia, PA 19104, USA.
Prions and similar self-templating proteins can spread, causing neurodegenerative diseases like Alzheimer's and Parkinson's. This transmissibility necessitates caution with new cell-based therapies to prevent disease spread.
Area of Science:
- Neuroscience
- Molecular Biology
- Protein Chemistry
Background:
- Prions are self-templating proteins causing transmissible diseases.
- Amyloid formation is not exclusive to prions and is linked to neurodegenerative disorders.
- Proteins like FUS and TDP-43, implicated in neurodegenerative diseases, share prion-like domains.
Purpose of the Study:
- To review advances in understanding the transmissibility of amyloid forms associated with neurodegenerative diseases.
- To explore the potential 'infectious' nature of proteins linked to Alzheimer's, Parkinson's, and Huntington's diseases.
- To reassess the safety and optimization of neuronal graft and stem-cell therapies in light of protein transmissibility.
Main Methods:
- Review of current scientific literature on prion diseases and protein misfolding.
- Analysis of studies demonstrating cell-to-cell spread of amyloid conformers in neurodegenerative conditions.
- Evaluation of the implications of protein transmissibility for therapeutic strategies.
Main Results:
- Amyloid conformers associated with Alzheimer's, Parkinson's, and Huntington's diseases can spread from cell to cell.
- This cell-to-cell spread contributes to the progression of distinct neurodegenerative phenotypes.
- The findings highlight the 'infectious' potential of misfolded proteins in the brain.
Conclusions:
- The transmissibility of amyloid conformers necessitates a re-evaluation of neuronal graft and stem-cell therapies.
- Strategies must be developed to mitigate the risk of transmitting these neurodegenerative agents through therapies.
- Optimizing treatments to overcome transmissible conformers is crucial for patient safety and therapeutic efficacy.
Related Concept Videos
Subviral Agents
Viral Recombination
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Reservoir of Infection
Rabies

